Why the study?
Does age over 50 impact survival in patients with soft tissue sarcoma?
Does age over 50 impact survival in patients with soft tissue sarcoma?
In patients with soft tissue sarcoma, being over 50 years of age is associated with inferior survival despite similar clinical features to younger patients.
Supports incorporating age into soft tissue sarcoma prognostication; leaves open whether age-tailored therapies improve survival.
With few exceptions, the clinical features of STS are similar in children and adults. However, individuals over 50 years of age have an inferior survival.
No takes yet. Share an insight, caveat, or question.
Ferrari et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: